Trans American Aquaculture (GRPS) Non-Current Debt (2022 - 2025)
Trans American Aquaculture (GRPS) reported Non-Current Debt of $145680.0 for Q3 2025, down 96.5% on a YoY basis from $4.2 million in Q3 2024, and little changed quarter-over-quarter from $145680.0 in Q2 2025.
Trans American Aquaculture (GRPS) Non-Current Debt (2022 - 2025) Analysis & Trends
Trans American Aquaculture has reported Non-Current Debt for 4 years, with the latest figure at $145680.0 in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Debt fell 96.5% year-over-year to $145680.0; the trailing twelve-month figure through Sep 2025 stood at $145680.0 (down 96.5% YoY), and the FY2024 full-year result was $561087.0, down 87.05% from the prior year.
- Non-Current Debt for Q3 2025 stood at $145680.0, roughly flat from $145680.0 in the prior quarter.
- The five-year high for Non-Current Debt was $4.6 million in Q4 2022, with the low at $145680.0 in Q2 2025.
- Historically, Non-Current Debt has averaged $2.8 million across 4 years, with a median of $4.2 million in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Debt declined 3.09% — and 2025, when it plunged 96.55%.
- Trans American Aquaculture's Non-Current Debt stood at $4.6 million in 2022, then retreated by 5.43% to $4.3 million in 2023, then slumped by 87.05% to $561087.0 in 2024, then plunged by 74.04% to $145680.0 in 2025.
- The last three Non-Current Debt figures came in at $145680.0 (Q3 2025), $145680.0 (Q2 2025), and $560870.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Trans American Aquaculture | - | - | - | 145,680.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 145,680.00 |
| Sep 30, 2025 | 145,680.00 |
| Jun 30, 2025 | 145,680.00 |
| Jun 30, 2025 | 145,680.00 |
| Mar 31, 2025 | 560,870.00 |
| Mar 31, 2025 | 560,870.00 |
| Dec 31, 2024 | 561,087.00 |
| Dec 31, 2024 | 561,087.00 |
| Sep 30, 2024 | 4.16 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | 4.58 Mn |
| Dec 31, 2022 | 4.58 Mn |